KPTI vs NOC · rev $68.5M vs P/E 17, rev $20.76B
Karyopharm Therapeutics Inc (KPTI) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
KPTI currently screens at market cap $205.6M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the KPTI and NOC stock pages for the full models.
Not investment advice.